Stem cell defect in aplastic anemia: Reduced long term culture-initiating cells (LTC-IC) in CD34+ cells isolated from aplastic anemia patient bone marrow

Hematology Journal

Volumn 3, Issue 5, 2002, Pages 230-236

  Rizzo, Sian ^a   Scopes, John ^a   Elebute, Modupe O ^a   Papadaki, Helen A ^a   Gordon Smith, Edward C ^a   Gibson, Frances M ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Aplastic anemia; CD34; Long term bone marrow culture; Long term culture initiating cells (LTC IC)

Indexed keywords

AUTOANTIGEN; CD34 ANTIGEN; CYCLOSPORIN A; DANAZOL; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HEPARIN; IMMUNOSUPPRESSIVE AGENT; METHYLPREDNISOLONE; OXYMETHOLONE; PENICILLIN G; STREPTOMYCIN; THYMOCYTE ANTIBODY;

ADULT; APLASTIC ANEMIA; ARTICLE; BONE MARROW CELL; CELL ASSAY; CELL CULTURE; CELL FUNCTION; CELL ISOLATION; CELL POPULATION; CLINICAL ARTICLE; CLINICAL FEATURE; COLONY FORMING CELL; CONTROLLED STUDY; DILUTION; DONOR; FREQUENCY ANALYSIS; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE DEFICIENCY; IMMUNOREGULATION; IMMUNOSUPPRESSIVE TREATMENT; IN VITRO STUDY; MONONUCLEAR CELL; PHENOTYPE; PURIFICATION; T LYMPHOCYTE; ADOLESCENT; BONE MARROW; CASE CONTROL STUDY; CELL COUNT; CELL DIVISION; CLONOGENIC ASSAY; CULTURE TECHNIQUE; MIDDLE AGED; PATHOLOGY;

ADOLESCENT; ADULT; ANEMIA, APLASTIC; ANTIGENS, CD34; BONE MARROW; CASE-CONTROL STUDIES; CELL COUNT; CELL CULTURE TECHNIQUES; CELL DIVISION; COLONY-FORMING UNITS ASSAY; HEMATOPOIETIC STEM CELLS; HUMANS; MIDDLE AGED;

EID: 0036430336     PISSN: 14664860     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.thj.6200187     Document Type: Article

References (31)

1. Socie G, Rosenfeld S, Frickhofen N, Gluckman E, Tichelli, A. Late clonal diseases of treated aplastic anemia. Sem Hematol 2000; 37: 91-101.
2. Marsh JC, Chang J, Testa NG, Hows JM, Dexter TM. The hematopoietic defect in aplastic anemia assessed by long-term marrow culture. Blood 1990; 76: 1748-1757.
3. Marsh JC, Chang J, Testa NG, Hows JM, Dexter TM. In vitro assessment of marrow 'stem cell' and stromal cell function in aplastic anaemia. Br J Haematol 1991; 78: 258-267.
4. Sutherland HJ, Eaves CJ, Eaves AC, Dragowska W, Lansdorp PM. Characterization and partial purification of human marrow cells capable of initiating long-term hematopoiesis in vitro. Blood 1989; 74: 1563-1570.
5. Issaad C, Croisille L, Katz A, Vainchenker W, Coulombel L. A murine stromal cell line allows the proliferation of very primitive human CD34 + +/CD38- progenitor cells in long-term cultures and semisolid assays. Blood 1993; 81: 2916-2924.
6. Ploemacher RE, Van der Sluijs JP, van Beurden CA, Baert MR, Chan PL. Use of limiting-dilution type long-term marrow cultures in frequency analysis of marrow-repopulating and spleen colony-forming hematopoietic stem cells in the mouse. Blood 1991; 78: 2527-2533.
7. Schrezenmeier H, Jenal M, Herrmann F, Heimpel H, Raghavachar A. Quantitative analysis of cobblestone area-forming cells in bone marrow of patients with aplastic anemia by limiting dilution assay. Blood 1996; 88: 4474-4480.
8. Andrews RG, Singer JW, Bernstein ID. Precursors of colony-forming cells in humans can be distinguished from colony-forming cells by expression of the CD33 and CD34 antigens and light scatter properties. J Exp Med 1989; 169: 1721-1731.
9. Maciejewski JP, Selleri C, Sato T, Anderson S, Young NS. A severe and consistent deficit in marrow and circulating primitive hematopoietic cells (long-term culture-initiating cells) in acquired aplastic anemia. 1996; Blood 88: 1983-1991.
10. Weaver A, Ryder WD, Testa NG. Measurement of long-term culture initiating cells (LTC-ICs) using limiting dilution: comparison of endpoints and stromal support. Exp Hematol 1997; 25: 1333-1338.
11. Podesta M, Piaggio G, Frassoni F, Pitto A, Zikos P. The assessment of the hematopoietic reservoir after immunosuppressive therapy or bone marrow transplantation in severe aplastic anemia. Blood 1998; 91: 1959-1965.
12. Koller MR, Manchel I, Smith AK. Quantitative long-term culture-initiating cell assays require accessory cell depletion that can be achieved by CD34-enrichment or 5-fluorouracil exposure. Blood 1998; 91: 4056-4064.
13. Philpott NJ, Scopes J, Marsh JC, Gordon-Smith EC, Gibson FM. Increased apoptosis in aplastic anemia bone marrow progenitor cells: possible pathophysiologic significance. Exp Hematol 1995; 23: 1642-1648.
14. Young NS. Hematopoietic cell destruction by immune mechanisms in acquired aplastic anemia. Sem Hematol 2000; 37: 3-14.
15. Camitta BM, Rappeport JM, Parkman R, Nathan DG. Selection of patients for bone marrow transplantation in severe aplastic anemia. Blood 1975; 45: 355-363.
16. Bacigalupo A, Hows J, Gluckman E, Nissen C, Marsh JC, Van Lint MT et al. Bone marrow transplantation (BMT) versus immunosuppression for the treatment of severe aplastic anaemia (SAA): a report of the EBMT SAA working party. Br J Haematol 1988; 70: 177-182.
17. Itoh K, Tezuka H, Sakoda H, Konno M, Nagata K, Uchiyama T et al. Reproducible establishment of hemopoietic supportive stromal cell lines from murine bone marrow. Exp Hematol 1989; 17: 145-153.
18. Taswell C. Limiting dilution assays for the determination of immunocompetent cell frequencies. I. Data analysis. J Immunol 1981; 126: 1614-1619.
19. Fazekas de St.Groth S. The evaluation of limiting dilution assays. J Immunol Methods 1982; 49: R11-R23.
20. Maciejewski JP, Selleri C, Sato T, Anderson S, Young NS. Increased expression of Fas antigen on bone marrow CD34+ cells of patients with aplastic anaemia. Br J Haematol 1995; 91: 245-252.
21. Sutherland HJ, Lansdorp PM, Henkelman DH, Eaves AC, Eaves CJ. Functional characterization of individual human hematopoietic stem cells cultured at limiting dilution on supportive marrow stromal layers. Proc Nat Acad Sci USA 1990; 87: 3584-3588.
22. Maciejewski JP, Anderson S, Katevas P, Young NS. Phenotypic and functional analysis of bone marrow progenitor cell compartment in bone marrow failure. Br J Haematol 1994; 87: 227-234.
23. Manz CY, Nissen C, Wodnar-Filipowicz A. Deficiency of CD34+ c-kit+ and CD34+38- hematopoietic precursors in aplastic anemia after immunosuppressive treatment. Am J Hematol 1996; 52: 264-274.
24. Bennaceur-Griscelli A, Tourino C, Izac B, Vainchenker W, Coulombel L. Murine stromal cells counteract the loss of long-term culture-initiating cell potential induced by cytokines in CD34(+)CD38(low/neg) human bone marrow cells. Blood 1999; 94: 529-538.
25. Koller MR, Oxender M, Jensen TC, Goltry KL, Smith AK. Direct contact between CD34 + lin- cells and stroma induces a soluble activity that specifically increases primitive hematopoietic cell production. Exp Hematol 1999; 27: 734-741.
26. Kojima S. (ed) Cytokine abnormalities in aplastic anemia, In: Schrezenmeier H, Bacigalupo A (eds.) Aplastic Anemia. Cambridge University Press, Cambridge, 2000; pp 21-40.
27. Rizzo S, Killick SB, Patel S, Ball SE, Wadhwa M, Dilger P. Reduced TGF-beta 1 in patients with aplastic anaemia in vivo and in vitro. Br J Haematol 1999; 107: 797-803.
28. Ogawa, M. Hematopoiesis. J Allergy Clin Immunol 1994; 94: 645-650.
29. Berardi AC, Wang A, Levine JD, Lopez P, Scadden DT. Functional isolation and characterization of human hematopoietic stem cells. Science 1995; 267: 104-108.
30. Killick SB, Cox CV, Marsh JCW, Gordon-Smith EC, Gibson FM. Mechanisms of bone marrow progenitor cell apoptosis in aplastic anaemia and the effect of antithymocyte globulin: examination of the role of the Fas-Fas-L interaction. Br J Haematol 2000; 111: 1164-1169.
31. Tichelli A, Schrezenmeier H, Bacigalupo A. (ed) Immunosuppressive Treatment of Aplastic Anemia, In: Schrezenmeier H, Bacigalupo A (eds.) Aplastic Anemia. Cambridge University Press, Cambridge, 2000; pp 154-196.